Based on this, Tsai et al. (2019) investigated an approach to deliver the gene encoding HNF4α and the chemotherapeutic drug cisplatin to hepatocellular carcinoma (HCC), via polyethyleneimine-modified MSNs (PMSNs). This evidence concerns the gene HNF4A and hepatocellular carcinoma.